ALS Surveillance in Massachusetts: A one-of-a-kind registry for tracking an elusive disease by Abille, Vannalyn et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Community Engagement and Research 
Symposia 
2017 Community Engagement and Research 
Symposium 
Mar 3rd, 8:00 AM 
ALS Surveillance in Massachusetts: A one-of-a-kind registry for 
tracking an elusive disease 
Vannalyn Abille 
Massachusetts Department of Public Health 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/chr_symposium 
 Part of the Civic and Community Engagement Commons, Clinical Epidemiology Commons, 
Community-Based Research Commons, Community Health and Preventive Medicine Commons, 
Environmental Public Health Commons, Epidemiology Commons, Nervous System Diseases Commons, 
and the Translational Medical Research Commons 
Repository Citation 
Abille V, Fraser A, Knorr R. (2017). ALS Surveillance in Massachusetts: A one-of-a-kind registry for tracking 
an elusive disease. Community Engagement and Research Symposia. https://doi.org/10.13028/
6fwt-2q07. Retrieved from https://escholarship.umassmed.edu/chr_symposium/2017/posters/12 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Community 
Engagement and Research Symposia by an authorized administrator of eScholarship@UMMS. For more information, 
please contact Lisa.Palmer@umassmed.edu. 
Amyotrophic Lateral Sclerosis (ALS) is a 
progressive and fatal neuromuscular disease 
with an etiology not yet fully understood. The 
Massachusetts Argeo Paul Cellucci ALS Registry is 
a unique population-based surveillance system 
used to monitor the occurrence of ALS 
throughout the state and to explore possible 
environmental causes of the disease. 
Background 
The Registry gathers annual reports of ALS cases 
from physicians, hospitals, and clinics in 
accordance with state regulations.  
 
• Medical records are obtained and abstracted 
for each case, and eligible cases are reviewed 
by a consulting neurologist to confirm 
diagnosis.  
• Necessary clinical and demographic information 
are recorded in a database and used by the 
Massachusetts Department of Public Health 
(MDPH) to prepare reports containing 
community-specific and statewide prevalence 
and incidence estimates. The data are also used 
to investigate spatial and temporal patterns and 
constitute a rich resource for researchers to 
explore environmental risk factors and whether 
they may impact disease rates. 
Methods 
Results and Conclusion 
Future of the Registry 
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Age in Years 
1148 cases verified 
as ALS 
1488 cases with complete 
files verified by a 
consulting neurologist 
  
More than 5168 total 
reports of ALS cases from 
2007-2011  
2287 unique cases identified after 
reports are de-duped  
 
  1780 eligible cases 
Data are available to inform patient service needs and epidemiologic studies.  Researchers can apply for 
access with the MDPH’s IRB.  A data report for years 2007 – 2014 is planned for release in early 2018. Future 
data updates and more information can be found on the ALS Registry website www.mass.gov/dph/ALS or 
contact Massachusetts-ALS-Registry@state.ma.us.  
Fig 1. Flow diagram of the 2007-2011 reported ALS 
cases through the registry verification process. 
Fig 2. Age-adjusted incidence rate (new diagnoses) and 
prevalence rate (all cases) of ALS from 2007-2011. 
Fig 3. Age-specific incidence rate from 2007-2011. 
Fig 4. Map of Massachusetts, highlighting areas that are  
statistically significantly different to the statewide prevalence rate. 
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ALS Surveillance in Massachusetts:  
A one-of-a-kind registry for tracking an elusive disease 
 
The result is a first-in-the-nation registry that allows for 
comprehensive capture of all ALS cases and complete 
verification of all reported cases.  
 
From 2007-2011, 826 new ALS cases were reported to 
MDPH. The average age-adjusted incidence rate from 
2007-2011 was 2.2 ALS cases per 100,000 population per 
year, and the average age–adjusted prevalence was 5.6 
per 100,000 - both comparable to the range of estimates 
reported in scientific literature. MDPH evaluated ALS 
occurrence similarly by community and other variables 
like age and family history.  
Characteristic Total No. (% of cases) 2009 Population of MA (% of population) 
Age group (years)     
     Under 30 2 (0.2)   2,536,045 (38.8)  
     30-39 14 (1.7)   843,045 (12.9)  
     40-49 82 (9.9)   984,450 (15.1)  
     50-59 182 (22.0)   909,046 (13.9)  
     60-69 235 (28.5)   616,877 (9.4)  
     70-79 203 (24.6)   358,831 (5.5)  
     ≥ 80 108 (13.1)   280,110 (4.3)  
Sex     
     Female  384 (46.5)  3,372,286 (51.7) 
     Male  442 (53.5)  3,156,118 (48.3) 
Total 826 (100.0) 6,528,404 (100.0) 
Table 1. Number of identified new ALS cases, by age 
group and sex (2007-2011) 
